000 | 01223 a2200313 4500 | ||
---|---|---|---|
005 | 20250517080512.0 | ||
264 | 0 | _c20160620 | |
008 | 201606s 0 0 eng d | ||
022 | _a1469-493X | ||
024 | 7 |
_a10.1002/14651858.CD005370.pub3 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAllingstrup, Mikkel | |
245 | 0 | 0 |
_aAntithrombin III for critically ill patients. _h[electronic resource] |
260 |
_bThe Cochrane database of systematic reviews _cFeb 2016 |
||
300 |
_aCD005370 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review | ||
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadverse effects |
650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
650 | 0 | 4 |
_aAntithrombin III _xadverse effects |
650 | 0 | 4 |
_aCritical Illness _xmortality |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
700 | 1 | _aWetterslev, Jørn | |
700 | 1 | _aRavn, Frederikke B | |
700 | 1 | _aMøller, Ann Merete | |
700 | 1 | _aAfshari, Arash | |
773 | 0 |
_tThe Cochrane database of systematic reviews _gvol. 2 _gp. CD005370 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/14651858.CD005370.pub3 _zAvailable from publisher's website |
999 |
_c25715070 _d25715070 |